Improvement of Skeletal Muscle Mass after Ledipasvir and Sofosbuvir Treatment for Hepatitis C Virus in Decompensated Liver Cirrhosis

gan Sakamori, Ryotaro, Yamada, Ryoko, Shinkai, Kazuma, Doi, Akira, Tahata, Yuki, Shigekawa, Minoru, Kodama, Takahiro, Hikita, Hayato, Yamada, Tomomi, Tatsumi, Tomohide, Takehara, Tetsuo
Cyhoeddwyd yn Intern Med (2021)

Pre-existing minor variants with NS5A L31M/V-Y93H double substitution are closely linked to virologic failure with asunaprevir plus daclatasvir treatment for genotype 1b hepatitis...

gan Morishita, Naoki, Sakamori, Ryotaro, Yamada, Tomomi, Kai, Yugo, Tahata, Yuki, Urabe, Ayako, Yamada, Ryoko, Kodama, Takahiro, Hikita, Hayato, Doi, Yoshinori, Tamura, Shinji, Hagiwara, Hideki, Imai, Yasuharu, Iio, Sadaharu, Tatsumi, Tomohide, Takehara, Tetsuo
Cyhoeddwyd yn PLoS One (2020)

Liver Fibrosis Is Associated With Corrected QT Prolongation During Ledipasvir/Sofosbuvir Treatment for Patients With Chronic Hepatitis C

gan Tahata, Yuki, Sakamori, Ryotaro, Urabe, Ayako, Morishita, Naoki, Yamada, Ryoko, Yakushijin, Takayuki, Hiramatsu, Naoki, Doi, Yoshinori, Kaneko, Akira, Hagiwara, Hideki, Yamada, Yukinori, Hijioka, Taizo, Inada, Masami, Tamura, Shinji, Imai, Yasuharu, Furuta, Kunimaro, Kodama, Takahiro, Hikita, Hayato, Tatsumi, Tomohide, Takehara, Tetsuo
Cyhoeddwyd yn Hepatol Commun (2018)